US 10533175
Compositions and methods for modulating Ataxin 3 expression
granted A61KA61K31/712
Quick answer
US patent 10533175 (Compositions and methods for modulating Ataxin 3 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 54
- CPC classes
- A61K, A61K31/712